Figure 2
From: Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers
Measurement of serum TFF3 levels in gastric cancer patients. Serum TFF3 levels were compared in gastric cancer patients. The significant ratios with P < 0.05 between 2 groups(clinical stage III/IV) and another 2 groups (clinical stage I-II/IV) (a) The significant ratios with P < 0.05 between 2 groups M0 (patients without distant metastasis) and M1 (patients with distant metastasis) (b), lymphatic metastasis after excluding the interference of distant metastasis (c) and number of lymphatic metastases (d).